Financial News
Articles published by Virpax Pharmaceuticals
Via Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
November 17, 2023
Via Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review
October 31, 2023
Via Business Wire
Tickers
VRPX
Via Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals
September 18, 2023
Via Business Wire
Tickers
VRPX
Via Business Wire
Tickers
VRPX
Virpax Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology (MET)
February 13, 2023
Via Business Wire
Tickers
VRPX
Virpax Will Pursue Direct to OTC Pathway for Epoladerm™ for Pain Associated with Osteoarthritis
June 27, 2022
Via Business Wire
Tickers
VRPX
Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021
September 02, 2021
Via Business Wire
Tickers
VRPX
Via Business Wire
Tickers
VRPX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.